A Community Built for Survivors and Clinicians Alike
The OncoMenopause Consortium is a specific education initiative of HERmedicine, a national 501(c)(3) nonprofit dedicated to advancing evidence-based women’s health. While part of the broader HERmedicine mission, the Consortium operates with its own Board and leads dedicated education initiatives for clinicians and consumers focused on the intersection of menopause and cancer survivorship.
Menopause management is complex. After cancer, it’s even more complicated.
Yet survivors deserve informed, coordinated, compassionate care—and clinicians need the tools, guidance, and community to provide it.
Cancer survivorship and menopause share remarkable parallels. Both require nuanced, individualized, evidence-based support. Yet too often, care in both areas remains fragmented, leaving individuals and their clinicians without the integrated resources they need.
The OncoMenopause Consortium was created to bridge this divide.
We unite experts across oncology, internal medicine, gynecology, endocrinology, nursing, pharmacy, psychology, and sexual health to share insights, strengthen education, and improve the delivery of care for individuals navigating menopause after cancer.
By connecting disciplines and amplifying evidence-based practice, we aim to redefine what survivorship and midlife health can look like—ensuring individuals receive comprehensive, coordinated care in the years beyond cancer.
Our Mission
To empower and support individuals navigating menopause after cancer by providing evidence-based education, clinical resources, and community connections that improve quality of life and promote informed conversations between patients and healthcare providers.
Our Vision
We envision a world where every person affected by cancer can experience menopause with confidence, compassion, and access to the best care and information available—bridging the gap between oncology and women’s health.
Our Founder
The OncoMenopause Consortium, founded by Lisa Larkin, MD, is a specific education initiative of HERmedicine, a 501(c)(3) nonprofit dedicated to advancing evidence-based women’s health.
Established to address the unique intersection of menopause and cancer survivorship, the Consortium strengthens multidisciplinary collaboration, advances clinical education, and supports the development of evidence-informed resources for individuals navigating menopause after cancer.
Lisa Larkin, MD, FACP, MSCP, IF
Lisa Larkin, MD, FACP, MSCP, IF, is a leader in internal medicine and women’s health with more than three decades of clinical experience and the unique perspective of being a breast cancer survivor. She is the founder of HERmedicine, a national 501(c)(3) nonprofit advancing evidence-based women’s health, and the founder and president of Ms.Medicine.
A Fellow of the American College of Physicians, a Certified Menopause Practitioner, and a Fellow of ISSWSH, Dr. Larkin maintains an active concierge internal medicine and women’s health practice focused on evidence-based care and long-term patient relationships.
She provides executive women’s health consultations and telemedicine services across multiple states, with expertise in menopause, sexual health, and preventive medicine. Dr. Larkin is recognized nationally for her leadership, innovation, and commitment to elevating standards of care in women’s health.
Our Executive Leadership Team
The OncoMenopause Consortium is guided by an Executive Leadership Team of nationally recognized clinicians whose expertise spans medical oncology, survivorship, supportive care, and women’s health. Amy Comander, MD; Maryam Lustberg, MD, MPH; Eleonora Teplinsky, MD; and Laila S. Agrawal, MD bring deep experience caring for individuals with breast and gynecologic cancers and play a central role in shaping the Consortium’s educational priorities, multidisciplinary programming, and clinician engagement efforts.
Maryam Lustberg, MD, MPH
Maryam Lustberg, MD, MPH, is Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center and Chief of Breast Medical Oncology. A Professor of Medicine, she is recognized nationally as one of Forbes’ top breast oncologists and by Castle Connolly as an “Exceptional Woman in Medicine.”
Her research focuses on improving long-term outcomes for individuals with breast cancer, with emphasis on treatment-related toxicities and the development of blood-based biomarkers to detect recurrence and side effects earlier. An NCI-funded investigator, she collaborates widely and leads multidisciplinary scientific teams advancing supportive oncology.
Dr. Lustberg serves on key ASCO committees, the Neuropathy Expert Guideline Panel, and is President-Elect of MASCC. She is an Associate Editor for the Journal of Cancer Survivorship and has authored more than 140 peer-reviewed publications. She earned her MD at the University of Maryland and her MPH at The Ohio State University.
Amy Comander, MD
Amy Comander, MD, FACLM, DipABLM, MSCP is a breast oncologist with expertise in women’s health and lifestyle medicine. She serves as Medical Director of the Mass General Brigham Cancer Institute in Waltham, and Director of the Lifestyle Medicine Program at the Mass General Brigham Cancer Institute. An Instructor at Harvard Medical School, she focuses on survivorship, lifestyle medicine, and improving long-term outcomes for individuals with breast cancer.
She is driven to help patients not only achieve their best cancer outcomes but also enhance their overall health and well-being. She has pursued board certification in Internal Medicine, Hematology, Medical Oncology, and Lifestyle Medicine, and she has received certification as a Menopause Practitioner. She is the co-creator of PAVING the Path to Wellness, a survivorship program based on the science of lifestyle medicine, in which breast cancer survivors learn strategies to optimize their health and well-being. She has recently published, "PAVING Your Path Through Breast Cancer and Beyond: Evidence-Based Lifestyle Medicine Tools for Cancer Survivorship."
Dr. Comander practices what she preaches, having run over 20 marathons, including 12 consecutive Boston Marathons to date, raising money to improve the lives of those with breast cancer. She is proud to serve on the Board of the PAVING the Path to Wellness non-profit organization. She also serves on the Board of the Ellie Fund, a non-profit organization that provides services and support to women diagnosed with breast cancer in Massachusetts. She serves as a medical advisor to the non-profit organizations SurvivingBreastCancer.org, the Tigerlily Foundation, and Oneinforty.
Eleonora Teplinsky, MD
Eleonora Teplinsky, MD, is a board-certified medical oncologist specializing in breast and gynecologic oncology. She is the head of breast and gynecologic medical oncology at Valley-Mount Sinai Comprehensive Cancer Care in Paramus, NJ and a Clinical Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai.
Her clinical and research interests focus on young women with breast cancer, survivorship, sexual health, and the use of social media in oncology. She is passionate about patient education, advocacy and empowerment on social media and is on social media herself as @drteplinsky.
Dr. Teplinsky serves on the medical advisory board of Living Beyond Breast Cancer, is a frequent media contributor, and is the host of the INTERLUDE Podcast where she shares the stories and experiences of those who have been affected by cancer. Her first book, Beyond the Pink, a patient-centered guide focusing on the physical and mental health challenges of breast cancer previvors, survivors, and thrivers, will be published in September 2026.
Laila S. Agrawal, MD
Laila Agrawa, MD, is a board-certified medical oncologist specializing in breast cancer at Norton Cancer Institute in Louisville, Kentucky. She completed her medical training at Indiana University School of Medicine, followed by an internal medicine residency at Barnes-Jewish Hospital at Washington University in St. Louis and a hematology/oncology fellowship at Vanderbilt University School of Medicine.
Dr. Agrawal has a special interest in women’s sexual health care during and after cancer treatment and leads a sexual health program. She is a fellow of the International Society for the Study of Women’s Sexual Health and serves on the boards of the Scientific Network on Female Sexual Health and Cancer and the Kentucky Society of Clinical Oncology.
She is committed to educating both patients and clinicians about sexual health and quality-of-life issues throughout cancer survivorship. She has authored articles and book chapters, speaks at national medical conferences and patient advocacy events, and shares evidence-based information through podcasts and social media.
Join the Movement
Join a multidisciplinary community of clinicians dedicated to improving outcomes and elevating care after cancer.
Founding Member: $50 for the first 200 members. After the first 200, annual membership is $125.
Join the Community
Become part of a supportive, growing community of survivors committed to learning, connecting, and thriving together after cancer.
survivHERs is entirely free to join.
Together, we’re building a space where knowledge, community, and confidence come together—so no one has to navigate survivorship alone.